Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Huilan Li, Yuanying Fang, Shuchun Guo & Zunhua Yang. (2021) GPR119 agonists for the treatment of type 2 diabetes: an updated patent review (2014-present). Expert Opinion on Therapeutic Patents 31:9, pages 795-808.
Read now
Read now
Yuanying Fang, Shaokun Zhang, Min Li, Lijuan Xiong, Liangxing Tu, Saisai Xie, Yi Jin, Yanhua Liu, Zunhua Yang & Ronghua Liu. (2020) Optimisation of novel 4, 8-disubstituted dihydropyrimido[5,4-b][1,4]oxazine derivatives as potent GPR 119 agonists. Journal of Enzyme Inhibition and Medicinal Chemistry 35:1, pages 50-58.
Read now
Read now
Robert M Jones, James N Leonard, Daniel J Buzard & Juerg Lehmann. (2009) GPR119 agonists for the treatment of type 2 diabetes. Expert Opinion on Therapeutic Patents 19:10, pages 1339-1359.
Read now
Read now
Articles from other publishers (41)
Priyanshu Nema, Vivek Asati, Priyadarshi Kendya, Twinkle Gupta, Shivangi Agarwal, Shivam Kori, Varsha Kashaw, Arun K. Iyer & Sushil Kumar Kashaw. (2023) Structural Insight on GPR119 Agonist as Potential Therapy for Type II
Diabetes: A Comprehensive Review. Mini-Reviews in Medicinal Chemistry 23:21, pages 2008-2040.
Crossref
Crossref
Hidayet TUTUN, Volkan İPEK, Musa TATAR, Ayşe KIZILYER & Muhammet Mükerrem KAYA. (2022) EXPRESSION AND DISTRIBUTION OF GPR55 AND GPR119 DURING THE DEVELOPMENT OF RAT TESTIS. Ankara Üniversitesi Veteriner Fakültesi Dergisi.
Crossref
Crossref
Jianan Zhao, Yu Zhao, Yiyang Hu & Jinghua Peng. (2021) Targeting the GPR119/incretin axis: a promising new therapy for metabolic-associated fatty liver disease. Cellular & Molecular Biology Letters 26:1.
Crossref
Crossref
Ajay Manaithiya, Ozair Alam, Vrinda Sharma, Mohd. Javed Naim, Shruti Mittal & Imran A Khan. (2021) GPR119 agonists: Novel therapeutic agents for type 2 diabetes mellitus. Bioorganic Chemistry 113, pages 104998.
Crossref
Crossref
Osamu Kubo, Kazuaki Takami, Masahiro Kamaura, Koji Watanabe, Hirohisa Miyashita, Shinichi Abe, Kae Matsuda, Yoshiyuki Tsujihata, Tomoyuki Odani, Shinji Iwasaki, Tomoyuki Kitazaki, Toshiki Murata & Kenjiro Sato. (2021) Discovery of a novel series of GPR119 agonists: Design, synthesis, and biological evaluation of N-(Piperidin-4-yl)-N-(trifluoromethyl)pyrimidin-4-amine derivatives. Bioorganic & Medicinal Chemistry 41, pages 116208.
Crossref
Crossref
Masahiro Kamaura, Osamu Kubo, Hiromichi Sugimoto, Naoyoshi Noguchi, Hirohisa Miyashita, Shinichi Abe, Kae Matsuda, Yoshiyuki Tsujihata, Tomoyuki Odani, Shinji Iwasaki, Toshiki Murata & Kenjiro Sato. (2021) Discovery of a novel series of indolinylpyrimidine-based GPR119 agonists: Elimination of ether-a-go-go-related gene liability using a hydrogen bond acceptor-focused approach. Bioorganic & Medicinal Chemistry 34, pages 116034.
Crossref
Crossref
Dong-Soon Im. (2021) GPR119 and GPR55 as Receptors for Fatty Acid Ethanolamides, Oleoylethanolamide and Palmitoylethanolamide. International Journal of Molecular Sciences 22:3, pages 1034.
Crossref
Crossref
Sergio Guzmán-Rodríguez, Jesús Chávez-Reyes, Priscila Vázquez-León, Marvin A. Soriano-Ursúa, Melvin N. Rosalez, Gonzalo Allende & Bruno A. Marichal-Cancino. (2021) 1-Boc-Piperidine-4-Carboxaldehyde Prevents Binge-Eating Behaviour and Anxiety in Rats. Pharmacology 106:5-6, pages 305-315.
Crossref
Crossref
Tae Hun Song, Sang Don Lee, Young Eun Ha, Kyung Jin Choi, Sang Hyun Lee, Young-Hoon Kim, Kwee Hyun Suh & Young-Jin Chun. (2019) HM47118A, a novel insulinotropic GPR119 agonist and potential oral antidiabetic agent. Diabetes Research and Clinical Practice.
Crossref
Crossref
Ivan N. Tyurenkov, Denis V. Kurkin, Dmitry A. Bakulin, Elena V. Volotova, Evgeny I. Morkovin, Mikhail A. Chafeev & Ruben N. Karapetian. (2018) Chemistry and Hypoglycemic Activity of GPR119 Agonist ZB-16. Frontiers in Endocrinology 9.
Crossref
Crossref
Kazuhito Harada, Jun Mizukami, Sho Kadowaki, Isamu Matsuda, Takashi Watanabe, Yasuhiro Oe, Yoshitoshi Kodama, Kenta Aoki, Katsunori Suwa, Sumiaki Fukuda, Shinji Yata & Takashi Inaba. (2018) Design and synthesis of novel and potent GPR119 agonists with a spirocyclic structure. Bioorganic & Medicinal Chemistry Letters 28:7, pages 1228-1233.
Crossref
Crossref
Larry Yet. 2018. Privileged Structures in Drug Discovery. Privileged Structures in Drug Discovery
155
193
.
Yoon Kyung Jang, Kyu Myung Lee, Kwan-Young Jung, Seung Kyu Kang, Suvarna H. Pagire, Jun Mi Lee, Haushabhau S. Pagire, Kwang Rok Kim, Myung Ae Bae, Hohjai Lee, Sang Dal Rhee & Jin Hee Ahn. (2017) Design, synthesis, and biological evaluation of aryl N-methoxyamide derivatives as GPR119 agonists. Bioorganic & Medicinal Chemistry Letters 27:16, pages 3909-3914.
Crossref
Crossref
Ivan N. Tyurenkov, Denis V. Kurkin, Dmitry A. Bakulin, Elena V. Volotova, Mikhail A. Chafeev, Alexey V. Smirnov & Evgeny I. Morkovin. (2017) ZB-16, a Novel GPR119 Agonist, Relieves the Severity of Streptozotocin–Nicotinamide-Induced Diabetes in Rats. Frontiers in Endocrinology 8.
Crossref
Crossref
Eun-Young Park, Eung-Hwi Kim, Chul-Young Kim, Mi-Hwi Kim, Jin-Seung Choung, Yoon-Sin Oh, Hong-Sub Moon & Hee-Sook Jun. (2016) Angelica dahurica Extracts Improve Glucose Tolerance through the Activation of GPR119. PLOS ONE 11:7, pages e0158796.
Crossref
Crossref
Kurt Ritter, Christian Buning, Nis Halland, Christoph Pöverlein & Lothar Schwink. (2015) G Protein-Coupled Receptor 119 (GPR119) Agonists for the Treatment of Diabetes: Recent Progress and Prevailing Challenges. Journal of Medicinal Chemistry 59:8, pages 3579-3592.
Crossref
Crossref
Christoffer Norn, Maria Hauge, Maja S. Engelstoft, Sun Hee Kim, Juerg Lehmann, Robert M. Jones, Thue W. Schwartz & Thomas M. Frimurer. (2015) Mutation-Guided Unbiased Modeling of the Fat Sensor GPR119 for High-Yield Agonist Screening. Structure 23:12, pages 2377-2386.
Crossref
Crossref
Andrzej Wasilewski, Martin Storr, Marta Zielińska & Jakub Fichna. (2015) Role of G Protein-coupled Orphan Receptors in Intestinal Inflammation. Inflammatory Bowel Diseases 21:3, pages 666-673.
Crossref
Crossref
James S. ScottSuzanne S. BowkerKaty J. BrocklehurstHayley S. BrownDavid S. ClarkeAlison EasterAnne Ertan, Kristin GoldbergJulian A. HudsonStefan KavanaghDavid LaberAndrew G. LeachPhilip A. MacFaulElizabeth A. MartinDarren McKerrecherPaul SchofieldPer H. Svensson & Joanne Teague. (2014) Circumventing Seizure Activity in a Series of G Protein Coupled Receptor 119 (GPR119) Agonists. Journal of Medicinal Chemistry 57:21, pages 8984-8998.
Crossref
Crossref
Moon-Kook Jeon, Kyu Myung Lee, Il Hyang Kim, Yoon Kyung Jang, Seung Kyu Kang, Jun Mi Lee, Kwan-Young Jung, Jaladi Ashok Kumar, Sang Dal Rhee, Won Hoon Jung, Jin Sook Song, Myung Ae Bae, Kwang Rok Kim & Jin Hee Ahn. (2014) Synthesis and biological evaluation of thienopyrimidine derivatives as GPR119 agonists. Bioorganic & Medicinal Chemistry Letters 24:17, pages 4281-4285.
Crossref
Crossref
Xiang-Yang Ye, Christian L. Morales, Ying Wang, Karen A. Rossi, Sarah E. Malmstrom, Mojgan Abousleiman, Larisa Sereda, Atsu Apedo, Jeffrey A. Robl, Keith J. Miller, John Krupinski & Dean A. Wacker. (2014) Synthesis and structure–activity relationship of dihydrobenzofuran derivatives as novel human GPR119 agonists. Bioorganic & Medicinal Chemistry Letters 24:11, pages 2539-2545.
Crossref
Crossref
Phil Alper, Mihai Azimioara, Christopher Cow, Daniel Mutnick, Victor Nikulin, Pierre-Yves Michellys, Zhiliang Wang, Esther Reding, Michael Paliotti, Jing Li, Dingjiu Bao, Jocelyn Zoll, Young Kim, Matthew Zimmerman, Todd Groessel, Tove Tuntland, Sean B. Joseph, Peter McNamara, H. Martin Seidel & Robert Epple. (2014) Discovery of structurally novel, potent and orally efficacious GPR119 agonists. Bioorganic & Medicinal Chemistry Letters 24:10, pages 2383-2387.
Crossref
Crossref
Brian M. Moran, Yasser H.A. Abdel-Wahab, Peter R. Flatt & Aine M. McKillop. (2014) Activation of GPR119 by fatty acid agonists augments insulin release from clonal β-cells and isolated pancreatic islets and improves glucose tolerance in mice. Biological Chemistry 395:4, pages 453-464.
Crossref
Crossref
Kenjiro Sato, Hiromichi Sugimoto, Kentaro Rikimaru, Hiroshi Imoto, Masahiro Kamaura, Nobuyuki Negoro, Yoshiyuki Tsujihata, Hirohisa Miyashita, Tomoyuki Odani & Toshiki Murata. (2014) Discovery of a novel series of indoline carbamate and indolinylpyrimidine derivatives as potent GPR119 agonists. Bioorganic & Medicinal Chemistry 22:5, pages 1649-1666.
Crossref
Crossref
Ming Yu, Jian (Ken) Zhang, Yingcai Wang, Jiang Zhu, Frank Kayser, Julio C. Medina, Karen Siegler, Marion Conn, Bei Shan, Mark P. Grillo, Peter Coward & Jiwen (Jim) Liu. (2014) Discovery and optimization of N-(3-(1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-4-yloxy)phenyl)benzenesulfonamides as novel GPR119 agonists. Bioorganic & Medicinal Chemistry Letters 24:1, pages 156-160.
Crossref
Crossref
Jian (Ken) Zhang, An-Rong Li, Ming Yu, Yingcai Wang, Jiang Zhu, Frank Kayser, Julio C. Medina, Karen Siegler, Marion Conn, Bei Shan, Mark P. Grillo, John Eksterowicz, Peter Coward & Jiwen (Jim) Liu. (2013) Discovery and optimization of arylsulfonyl 3-(pyridin-2-yloxy)anilines as novel GPR119 agonists. Bioorganic & Medicinal Chemistry Letters 23:12, pages 3609-3613.
Crossref
Crossref
James S. Scott, Katy J. Brocklehurst, Hayley S. Brown, David S. Clarke, Helen Coe, Sam D. Groombridge, David Laber, Philip A. MacFaul, Darren McKerrecher & Paul Schofield. (2013) Conformational restriction in a series of GPR119 agonists: Differences in pharmacology between mouse and human. Bioorganic & Medicinal Chemistry Letters 23:11, pages 3175-3179.
Crossref
Crossref
James S. Scott, Alan M. Birch, Katy J. Brocklehurst, Hayley S. Brown, Kristin Goldberg, Sam D. Groombridge, Julian A. Hudson, Andrew G. Leach, Philip A. MacFaul, Darren McKerrecher, Ruth Poultney, Paul Schofield & Per H. Svensson. (2013) Optimisation of aqueous solubility in a series of G protein coupled receptor 119 (GPR119) agonists. MedChemComm 4:1, pages 95-100.
Crossref
Crossref
Subba R. Katamreddy, Andrew J. Carpenter, Carina E. Ammala, Eric E. Boros, Ron L. Brashear, Celia P. Briscoe, Sarah R. Bullard, Richard D. Caldwell, Christopher R. Conlee, Dallas K. Croom, Shane M. Hart, Dennis O. Heyer, Paul R. Johnson, Jennifer A. Kashatus, Doug J. Minick, Gregory E. Peckham, Sean A. Ross, Shane G. Roller, Vicente A. Samano, Howard R. Sauls, Sarva M. Tadepalli, James B. Thompson, Yun Xu & James M. Way. (2012)
Discovery of 6,7-Dihydro-5
H
-pyrrolo[2,3-
a
]pyrimidines as Orally Available G Protein-Coupled Receptor 119 Agonists
. Journal of Medicinal Chemistry 55:24, pages 10972-10994.
Crossref
Crossref
Masao Sakairi, Masakazu Kogami, Masafumi Torii, Hiroyo Kataoka, Hiroki Fujieda, Mitsuhiro Makino, Daisuke Kataoka, Ryuji Okamoto, Toshiyuki Miyazawa, Morio Okabe, Megumi Inoue, Naoki Takahashi, Satoko Harada & Nobuhide Watanabe. (2012) Synthesis and SAR studies of bicyclic amine series GPR119 agonists. Bioorganic & Medicinal Chemistry Letters 22:15, pages 5123-5128.
Crossref
Crossref
James S. Scott, Alan M. Birch, Katy J. Brocklehurst, Anders Broo, Hayley S. Brown, Roger J. Butlin, David S. Clarke, Öjvind Davidsson, Anne Ertan, Kristin Goldberg, Sam D. Groombridge, Julian A. Hudson, David Laber, Andrew G. Leach, Philip A. MacFaul, Darren McKerrecher, Adrian Pickup, Paul Schofield, Per H. Svensson, Pernilla Sörme & Joanne Teague. (2012) Use of Small-Molecule Crystal Structures To Address Solubility in a Novel Series of G Protein Coupled Receptor 119 Agonists: Optimization of a Lead and in Vivo Evaluation. Journal of Medicinal Chemistry 55:11, pages 5361-5379.
Crossref
Crossref
Katy J. Brocklehurst, Anders Broo, Roger J. Butlin, Hayley S. Brown, David S. Clarke, Öjvind Davidsson, Kristin Goldberg, Sam D. Groombridge, Elizabeth E. Kelly, Andrew Leach, Darren McKerrecher, Charles O’Donnell, Simon Poucher, Paul Schofield, James S. Scott, Joanne Teague, Leanne Westgate & Matt J.M. Wood. (2011) Discovery, optimisation and in vivo evaluation of novel GPR119 agonists. Bioorganic & Medicinal Chemistry Letters 21:24, pages 7310-7316.
Crossref
Crossref
Xiaoyun Zhu, Dandan Huang, Xiaobu Lan, Chunlei Tang, Yan Zhu, Jing Han, Wenlong Huang & Hai Qian. (2011) The first pharmacophore model for potent G protein-coupled receptor 119 agonist. European Journal of Medicinal Chemistry 46:7, pages 2901-2907.
Crossref
Crossref
Yan Xia, Samuel Chackalamannil, William J. Greenlee, Charles Jayne, Bernard Neustadt, Andrew Stamford, Henry Vaccaro, Xiaoying (Lucy) Xu, Hana Baker, Kim O’Neill, Morgan Woods, Brian Hawes & Tim Kowalski. (2011) Discovery of a nortropanol derivative as a potent and orally active GPR119 agonist for type 2 diabetes. Bioorganic & Medicinal Chemistry Letters 21:11, pages 3290-3296.
Crossref
Crossref
Jason W. Szewczyk, John Acton, Alan D. Adams, Gary Chicchi, Stanley Freeman, Andrew D. Howard, Yong Huang, Cai Li, Peter T. Meinke, Ralph Mosely, Elizabeth Murphy, Rachel Samuel, Conrad Santini, Meng Yang, Yong Zhang, Kake Zhao & Harold B. Wood. (2011) Design of potent and selective GPR119 agonists for type II diabetes. Bioorganic & Medicinal Chemistry Letters 21:9, pages 2665-2669.
Crossref
Crossref
Kim F. McClure, Etzer Darout, Cristiano R. W. Guimarães, Michael P. DeNinno, Vincent Mascitti, Michael J. Munchhof, Ralph P. Robinson, Jeffrey Kohrt, Anthony R. Harris, Dianna E. Moore, Bryan Li, Lacey Samp, Bruce A. Lefker, Kentaro Futatsugi, Daniel Kung, Paul D. Bonin, Peter Cornelius, Ruduan Wang, Eben Salter, Sam Hornby, Amit S. Kalgutkar & Yue Chen. (2011) Activation of the G-Protein-Coupled Receptor 119: A Conformation-Based Hypothesis for Understanding Agonist Response. Journal of Medicinal Chemistry 54:6, pages 1948-1952.
Crossref
Crossref
Donald J. AbrahamJefferson Tilley, Joseph Grimsby, Shawn Erickson & Steven Berthel. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
38
.
Yulin Wu, Judith D. Kuntz, Andrew J. Carpenter, Jing Fang, Howard R. Sauls, Daniel J. Gomez, Carina Ammala, Yun Xu, Shane Hart & Sarva Tadepalli. (2010) 2,5-Disubstituted pyridines as potent GPR119 agonists. Bioorganic & Medicinal Chemistry Letters 20:8, pages 2577-2581.
Crossref
Crossref
Unmesh Shah & Timothy J. Kowalski. 2010. Incretins and Insulin Secretion. Incretins and Insulin Secretion
415
448
.
Eric E. Boros, James B. Thompson, Subba R. Katamreddy & Andrew J. Carpenter. (2009) Facile Reductive Amination of Aldehydes with Electron-Deficient Anilines by Acyloxyborohydrides in TFA: Application to a Diazaindoline Scale-Up. The Journal of Organic Chemistry 74:9, pages 3587-3590.
Crossref
Crossref
Graeme Semple, Beatriz Fioravanti, Guillherme Pereira, Imelda Calderon, Jane Uy, Karoline Choi, Yifeng Xiong, Albert Ren, Michael Morgan, Vibha Dave, William Thomsen, David J. Unett, Charles Xing, Stuart Bossie, Chris Carroll, Zhi-Liang Chu, Andrew J. Grottick, Erin K. Hauser, James Leonard & Robert M. Jones. (2008) Discovery of the First Potent and Orally Efficacious Agonist of the Orphan G-Protein Coupled Receptor 119. Journal of Medicinal Chemistry 51:17, pages 5172-5175.
Crossref
Crossref